Moderna MRNA Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$2.82B+20.8% | -$3.56B+27.8% | -$4.93B-159% | $8.36B-31.5% | ||
| $215M+13.8% | $189M-69.6% | $621M+78.4% | $348M+50.0% | ||
| $483M+12.6% | $429M+40.7% | $305M+35.0% | $226M+59.2% | ||
| -$156M+72.1% | -$560M-13.6% | -$493M+72.5% | -$1.79B— | ||
| —— | -$83M+88.9% | -$747M-51.8% | -$492M-135% | ||
| —— | —— | $13M-94.6% | $240M+8.1% | ||
| —— | —— | -$340M-156% | $612M-38.1% | ||
| -$153M-5.5% | -$145M+92.0% | -$1.8B-177% | $2.35B+380% | ||
| —— | $78M-11.4% | $88M+112% | -$740M— | ||
| -$77M-26.2% | -$61M— | —— | —— | ||
| —— | -$439M+78.7% | -$2.06B+50.4% | -$4.16B— | ||
| -$21M— | —— | $605M— | —— | ||
| —— | -$52M-48.6% | -$35M— | $0— | ||
| —— | —— | —— | $4.98B-63.4% | ||
| $192M-81.7% | $1.05B+48.7% | $707M+76.8% | $400M+40.8% | ||
| $5.77B-11.7% | $6.53B+73.6% | $3.76B-67.1% | $11.44B-9.6% | ||
| $2.35B-40.7% | $3.97B+23.7% | $3.21B-9.6% | $3.55B+14.3% | ||
| —— | $0— | $0— | —— | ||
| $1.99B— | —— | —— | —— | ||
| $600M— | $0— | $0— | —— | ||
| $35M-47.0% | $66M+43.5% | $46M— | $0— | ||
| —— | —— | —— | —— | ||
| $22M— | $0— | $0— | —— | ||
| $594M+907% | $59M+104% | -$1.38B+60.1% | -$3.45B-295% | ||
| $2M— | —— | —— | —— | ||
| $668M— | —— | -$289M— | —— | ||
| $10M-58.3% | $24M-38.5% | $39M+56.0% | $25M+78.6% | ||
| $26M-86.8% | $197M+155% | -$357M-113% | $2.73B+469% | ||
| —— | -$52M-48.6% | -$35M— | $0— | ||
| -$21M— | —— | $605M— | —— | ||
| -$153M-5.5% | -$145M+92.0% | -$1.8B-177% | $2.35B+380% | ||
| -$38M— | —— | $657M— | —— | ||
| $67M-29.5% | $95M+55.7% | $61M— | —— | ||
| $215M+13.8% | $189M-69.6% | $621M— | —— | ||
| -$77M-26.2% | -$61M— | —— | —— | ||
| —— | $0— | $0— | —— | ||
| $5.56B0.0% | $5.56B-0.2% | $5.58B+76.9% | $3.15B+136% | ||
| $2.35B-40.7% | $3.97B+23.7% | $3.21B-9.6% | $3.55B+14.3% | ||
| $18M+80.0% | $10M-96.3% | $270M+46.7% | $184M+31.4% | ||
| $22M— | $0— | $0— | —— | ||
| $35M-47.0% | $66M+43.5% | $46M-29.2% | $65M-47.6% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $26M-86.8% | $197M+155% | -$357M-113% | $2.73B+469% | ||
| —— | -$4.36B— | —— | $4.58B-65.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Moderna generate?
- Moderna (MRNA) generated -$3.4B in operating cash flow over the trailing twelve months.
- What is Moderna's free cash flow?
- After $137.0M of capital expenditures, Moderna's free cash flow was -$3.6B over the trailing twelve months, up 16.3% year over year.
- Where does Moderna's cash flow data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
